News & Updates
Filter by Specialty:
What do young T1DM patients look for in ketone breath sensors?
Young patients with type 1 diabetes mellitus (T1DM) find the noninvasive nature of ketone breath sensor devices attractive, especially as compared with blood testing, according to a recent study. Still, concerns about such devices remain, including their ease of use, accuracy, and affordability.
What do young T1DM patients look for in ketone breath sensors?
08 Aug 2022
Obesity, metabolic comorbidities linked to large hepatocellular adenoma, adenomatosis
Obesity and metabolic comorbidities appear to be common among patients with large hepatocellular adenomas (HCAs) and adenomatosis, reports a study.
Obesity, metabolic comorbidities linked to large hepatocellular adenoma, adenomatosis
07 Aug 2022
Overweight, obesity do not worsen disease activity for children with IBD
In children with newly diagnosed inflammatory bowel disease (IBD), overweight and obese status are not associated with worse disease activity at 1 year after diagnosis compared with normal weight, results of a study have shown.
Overweight, obesity do not worsen disease activity for children with IBD
05 Aug 2022
SGLT2 inhibitors show renal benefits vs GLP-1 RAs in T2D patients in the real world
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are superior to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing renal outcomes among patients with type 2 diabetes (T2D) in Hong Kong, a real-world population-based study by the University of Hong Kong has shown.
SGLT2 inhibitors show renal benefits vs GLP-1 RAs in T2D patients in the real world
02 Aug 2022
Fezolinetant reduces hot flashes during menopause
The neurokinin-3 receptor antagonist fezolinetant reduced the frequency and severity of menopause-associated vasomotor symptoms (VMS), according to results of the extension arm of the phase III Skylight 2 trial presented at ENDO 2022.
